Neuroprotection Is Unlikely to Be Effective in Humans Using Current Trial Designs: An Opposing View
- 1 January 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (1), 308-309
- https://doi.org/10.1161/str.33.1.308
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Prospects for improved neuroprotection trials in strokePublished by Cambridge University Press (CUP) ,2002
- Glycine Antagonist in Neuroprotection for Patients With Acute StrokeJAMA, 2001
- Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trialThe Lancet, 2000
- NeuroprotectionBritish Medical Bulletin, 2000
- Inference on Multiple Endpoints in Clinical Trials with Adaptive Interim AnalysesBiometrical Journal, 1999